INTEGRIS is a clinical research site located in Oklahoma City, Oklahoma, United States 73112.
Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.
INTEGRIS has participated in 2 clinical trials.
Therapeutic areas: Heart Failure, Diabetes Mellitus, Type 2, Congestive Heart Failure.
Sponsors: Vanderbilt University Medical Center, University of Michigan.
Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
INTEGRIS has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
INTEGRIS has 2 clinical trials on record. Their work covers Heart Failure, Diabetes Mellitus, Type 2, Congestive Heart Failure.
INTEGRIS has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.